Merck upgraded to Overweight at Morgan Stanley, target raised to $179
Merck (MRK) is upgraded to Overweight from Equal Weight at Morgan Stanley, which also raises its price target to $179 from $116.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.